Patents-Review.com
🔗 Permalink
Assignee profile:

VALERION THERAPEUTICS, LLC

City:

Concord, Massachusetts

Country:

United States

Published Applications:

13

Last publication date:

2020-07-16

Patent Grants:

13

Last grant date:

2020-09-22

Top Inventors for applications by VALERION THERAPEUTICS, LLC

These are the the leading inventors for applications assigned to VALERION THERAPEUTICS, LLC:

Recent patent applications by VALERION THERAPEUTICS, LLC

VALERION THERAPEUTICS, LLC based in Concord, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2020-07-16 ✅ Patent 10,781,434 granted on 2020-09-22
US20200224184A1
Chemistry; metallurgy

Methods and compositions for treatment of glycogen storage diseases and glycogen metabolism disorders

 #2 | 2019-10-17 ✅ Patent 10,781,433 granted on 2020-09-22
US20190316104A1
Chemistry; metallurgy

Methods and compositions for treatment of Lafora disease

 #3 | 2019-09-26 ✅ Patent 10,703,824 granted on 2020-07-07
US20190292276A1
Chemistry; metallurgy

Internalizing moieties

 #4 | 2018-05-10 ✅ Patent 10,501,554 granted on 2019-12-10
US20180127509A1
Chemistry; metallurgy

Internalizing moieties for treatment of cancer

 #5 | 2018-01-25 ✅ Patent 10,238,753 granted on 2019-03-26
US20180021449A1
Human necessities

Antisense conjugates for decreasing expression of DMPK

 #6 | 2017-06-22 ✅ Patent 10,221,250 granted on 2019-03-05
US20170174790A1
Chemistry; metallurgy

Internalizing moieties

 #7 | 2017-05-11 ✅ Patent 10,202,591 granted on 2019-02-12
US20170130216A1
Chemistry; metallurgy

Methods and compositions for treatment of glycogen storage diseases and glycogen metabolism disorders

 #8 | 2016-04-21 ✅ Patent 10,017,581 granted on 2018-07-10
US20160108133A1
Chemistry; metallurgy

Methods and compositions for treatment of Pompe disease

 #9 | 2015-08-06 ✅ Patent 9,447,394 granted on 2016-09-20
US20150218540A1
Chemistry; metallurgy

Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularin 1(MTM1) polypeptides

 #10 | 2015-03-05 ✅ Patent 9,610,362 granted on 2017-04-04
US20150064181A1
Human necessities

Antisense conjugates for decreasing expression of DMPK

 #11 | 2014-06-26 ✅ Patent 9,114,178 granted on 2015-08-25
US20140178377A1
Human necessities

Methods and compositions for treatment of myotonic dystrophy

 #12 | 2012-08-23 ✅ Patent 8,834,866 granted on 2014-09-16
US20120213760A1
Chemistry; metallurgy

Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularin 1(MTM1) polypeptides

 #13 | 2010-05-06 ✅ Patent 8,609,615 granted on 2013-12-17
US20100111977A1
Chemistry; metallurgy

Methods and compositions for treatment of myotonic dystrophy

Also check out Valerion Therapeutics, LLC's (Concord, United States) applicant profile with 11 patent applications submitted.

AssigneeID:

69407 ⎘